Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries
<p>Abstract</p> <p>Background</p> <p>Little is known about the role European patient organisations play in the process of deciding on reimbursement for medicines. Therefore we <it>explore </it>the current role of patient organisations in the process of reimb...
Main Authors: | Friele Roland, van Dijk Liset, Noordman Janneke |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-02-01
|
Series: | BMC Health Services Research |
Online Access: | http://www.biomedcentral.com/1472-6963/10/45 |
Similar Items
-
Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
by: Paweł Kawalec, et al.
Published: (2017-06-01) -
Active Involvement of End Users When Developing Web-Based Mental Health Interventions
by: Derek de Beurs, et al.
Published: (2017-05-01) -
Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
by: Ewa Stawowczyk, et al.
Published: (2019-11-01) -
Reimbursement process of medicinal products in Poland and in the world
by: Aneta Katarzyna Mela
Published: (2020-09-01) -
Geography of medication reimbursements in Belgium: an exploratory analysis
by: Sonia Trabelsi, et al.
Published: (2021-06-01)